XT
FLGT icon

XTX Topco’s Fulgent Genetics FLGT Stock Holding History

XTX Topco’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-92,499
Closed -$1.47M – 4310
2026
Q1 		$1.47M Buy
92,499
+70,304
+317% +$1.53M 0.03% 1096
2025
Q4 		$583K Buy
22,195
+5,523
+33% +$143K 0.02% 1466
2025
Q3 		$377K Buy
16,672
+297
+2% +$6.12K 0.02% 1312
2025
Q2 		$326K Sell
16,375
-2,774
-14% -$54.1K 0.01% 1373
2025
Q1 		$324K Buy
+19,149
New +$326K 0.02% 1344
2022
Q3 		– Sell
-4,489
Closed -$245K – 1183
2022
Q2 		$245K Buy
+4,489
New +$247K 0.1% 367

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

XTX Topco's FLGT Position: Q2 2026 in Review

XTX Topco sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 92,499 shares — an estimated $1.47M sold.

XTX Topco first reported a position in FLGT in Q2 2022 and held it in 6 quarters. The position peaked at $1.47M in Q1 2026. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • XTX Topco reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 92,499 Fulgent Genetics shares in Q2 2026, an estimated $1.47M.
  • XTX Topco first reported a position in Fulgent Genetics in Q2 2022 and held it in 6 quarters.
  • XTX Topco's Fulgent Genetics position peaked at $1.47M in Q1 2026.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.